Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2025)

Benitec Biopharma has reported Other Operating Expenses over the past 7 years, most recently at -$5.6 million for Q1 2025.

  • Quarterly results put Other Operating Expenses at -$5.6 million for Q1 2025, down 185100.0% from a year ago — trailing twelve months through Dec 2025 was -$5.6 million (down 209.61% YoY), and the annual figure for FY2024 was -$108000.0, changed.
  • Other Operating Expenses reached -$5.6 million in Q1 2025 per BNTC's latest filing, down from $5.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $5.1 million in Q4 2024 and bottomed at -$5.6 million in Q1 2025.
  • Median Other Operating Expenses over the past 5 years was $1000.0 (2021), compared with a mean of -$71875.0.
  • The largest annual shift saw Other Operating Expenses soared 507100.0% in 2024 before it crashed 185100.0% in 2025.
  • Over 5 years, Other Operating Expenses stood at $1000.0 in 2021, then soared by 800.0% to $9000.0 in 2022, then crashed by 88.89% to $1000.0 in 2023, then skyrocketed by 507100.0% to $5.1 million in 2024, then plummeted by 209.54% to -$5.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for BNTC at -$5.6 million in Q1 2025, $5.1 million in Q4 2024, and -$3000.0 in Q1 2024.